PRODH polymorphisms, cortical volumes and thickness in schizophrenia

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Ota, Vanessa K ^a   Bellucco, Fernanda T ^a   Gadelha, Ary ^a   Santoro, Marcos L ^a   Noto, Cristiano ^a   Christofolini, Denise M ^b   Assunção, Idaiane B ^a   Yamada, Karen M ^a   Ribeiro dos Santos, Ândrea K ^c   Santos, Sidney ^c   Mari, Jair J ^a   Smith, Marília A C ^a   Melaragno, Maria I ^a   Bressan, Rodrigo A ^a   Sato, João R ^a,d   Jackowski, Andrea P ^a   Belangero, Sintia I ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b FACULDADE DE MEDICINA DO ABC   (Brazil)

^c FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^d UNIVERSIDADE FEDERAL DO ABC   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

PROLINE DEHYDROGENASE; PRODH PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; BRAIN CORTEX; BRAIN FUNCTION; BRAIN SIZE; CALGARY DEPRESSION SCALE; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; CORTICAL THICKNESS (BRAIN); FEMALE; GENETIC POLYMORPHISM; GENOTYPE; GLOBAL ASSESSMENT OF FUNCTIONING; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; POSITIVE AND NEGATIVE SYNDROME SCALE; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHIZOPHRENIA; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ENZYMOLOGY; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY; POLYMERASE CHAIN REACTION; PSYCHOLOGICAL RATING SCALE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CEREBRAL CORTEX; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROLINE OXIDASE; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA;

EID: 84896887833     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087686     Document Type: Article

References (55)

1. Weinberger DR (1987) Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44: 660-669.
2. Weinberger DR (1995) From neuropathology to neurodevelopment. Lancet 346: 552-557.
3. Murray RM, Lewis SW (1987) Is schizophrenia a neurodevelopmental disorder? Br Med J (Clin Res Ed) 295: 681-682. (Pubitemid 17137921)
4. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE (2005) Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62: 617-627. (Pubitemid 40973437)
5. Saha S, Chant D, Welham J, McGrath J (2005) A systematic review of the prevalence of schizophrenia. PLoS Med 2: e141.
6. Cannon TD, Kaprio J, Lonnqvist J, Huttunen M, Koskenvuo M (1998) The genetic epidemiology of schizophrenia in a Finnish twin cohort. A population-based modeling study. Arch Gen Psychiatry 55: 67-74. (Pubitemid 28069041)
7. Lichtenstein P, Yip BH, Bjork C, Pawitan Y, Cannon TD, et al. (2009) Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 373: 234-239.
8. Gejman PV, Sanders AR, Kendler KS (2011) Genetics of schizophrenia: new findings and challenges. Annu Rev Genomics Hum Genet 12: 121-144.
9. Levinson DF, Duan J, Oh S, Wang K, Sanders AR, et al. (2011) Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. Am J Psychiatry 168: 302-316.
10. Pulver AE, Nestadt G, Goldberg R, Shprintzen RJ, Lamacz M, et al. (1994) Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. J Nerv Ment Dis 182: 476-478. (Pubitemid 24263483)
11. Christofolini DM, Bellucco FT, Ota VK, Belangero SI, Cernach MC, et al. (2011) Assessment of 22q11.2 copy number variations in a sample of Brazilian schizophrenia patients. Schizophr Res 132: 99-100.
12. Hoogendoorn ML, Vorstman JA, Jalali GR, Selten JP, Sinke RJ, et al. (2008) Prevalence of 22q11.2 deletions in 311 Dutch patients with schizophrenia. Schizophr Res 98: 84-88. (Pubitemid 350235900)
13. Horowitz A, Shifman S, Rivlin N, Pisante A, Darvasi A (2005) A survey of the 22q11 microdeletion in a large cohort of schizophrenia patients. Schizophr Res 73: 263-267. (Pubitemid 40093888)
14. Karayiorgou M, Morris MA, Morrow B, Shprintzen RJ, Goldberg R, et al. (1995) Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc Natl Acad Sci U S A 92: 7612-7616.
15. Mitsubuchi H, Nakamura K, Matsumoto S, Endo F (2008) Inborn errors of proline metabolism. J Nutr 138: 2016S-2020S.
16. Shaikh TH, Kurahashi H, Saitta SC, O'Hare AM, Hu P, et al. (2000) Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis. Hum Mol Genet 9: 489-501. (Pubitemid 30154007)
17. Gogos JA, Santha M, Takacs Z, Beck KD, Luine V, et al. (1999) The gene encoding proline dehydrogenase modulates sensorimotor gating in mice. Nat Genet 21: 434-439. (Pubitemid 29159584)
18. Liu W, Phang JM (2012) Proline dehydrogenase (oxidase), a mitochondrial tumor suppressor, and autophagy under the hypoxia microenvironment. Autophagy 8: 1407-1409.
19. Liu W, Le A, Hancock C, Lane AN, Dang CV, et al. (2012) Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC. Proc Natl Acad Sci U S A 109: 8983-8988.
20. Nadler JV (1987) Sodium-dependent proline uptake in the rat hippocampal formation: association with ipsilateral-commissural projections of CA3 pyramidal cells. J Neurochem 49: 1155-1160.
21. Nadler JV, Bray SD, Evenson DA (1992) Autoradiographic localization of proline uptake in excitatory hippocampal pathways. Hippocampus 2: 269-278.
22. Cohen SM, Nadler JV (1997) Proline-induced potentiation of glutamate transmission. Brain Res 761: 271-282. (Pubitemid 27305987)
23. Phang J, Hu C, Valle D (2001) Disorders of proline and hydroxyproline metabolism; Scriver C, Beaudet A, Sly W, Valle D, editors. New York: McGraw Hill. pp1821-1838 p.
24. Goodman BK, Rutberg J, Lin WW, Pulver AE, Thomas GH (2000) Hyperprolinaemia in patients with deletion (22)(q11.2) syndrome. J Inherit Metab Dis 23: 847-848. (Pubitemid 32036721)
25. Raux G, Bumsel E, Hecketsweiler B, van Amelsvoort T, Zinkstok J, et al. (2007) Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome. Hum Mol Genet 16: 83-91. (Pubitemid 46152546)
26. Baxter CF, Baldwin RA, Davis JL, Flood JF (1985) High proline levels in the brains of mice as related to specific learning deficits. Pharmacol Biochem Behav 22: 1053-1059. (Pubitemid 15033482)
27. Davis JL, Pico RM, Flood JF (1987) Differences in learning between hyperprolinemic mice and their congenic controls. Behav Neural Biol 48: 128-137. (Pubitemid 17110937)
28. Tan GM, Arnone D, McIntosh AM, Ebmeier KP (2009) Meta-analysis of magnetic resonance imaging studies in chromosome 22q11.2 deletion syndrome (velocardiofacial syndrome). Schizophr Res 115: 173-181.
29. Shepherd AM, Laurens KR, Matheson SL, Carr VJ, Green MJ (2012) Systematic meta-review and quality assessment of the structural brain alterations in schizophrenia. Neurosci Biobehav Rev 36: 1342-1356.
30. Zugman A, Gadelha A, Assuncao I, Sato J, Ota VK, et al. (2013) Reduced dorso-lateral prefrontal cortex in treatment resistant schizophrenia. Schizophr Res 148: 81-86.
31. Kempf L, Nicodemus KK, Kolachana B, Vakkalanka R, Verchinski BA, et al. (2008) Functional polymorphisms in PRODH are associated with risk and protection for schizophrenia and fronto-striatal structure and function. PLoS Genet 4: e1000252.
32. Zinkstok J, Schmitz N, van Amelsvoort T, Moeton M, Baas F, et al. (2008) Genetic variation in COMT and PRODH is associated with brain anatomy in patients with schizophrenia. Genes Brain Behav 7: 61-69.
33. Bressan RA, Chaves AC, Shirakawa I, de Mari J (1998) Validity study of the Brazilian version of the Calgary Depression Scale for Schizophrenia. Schizophr Res 32: 41-49. (Pubitemid 28338123)
34. Lima MS, Soares BG, Paoliello G, Machado Vieira R, Martins CM, et al. (2007) The Portuguese version of the Clinical Global Impression-Schizophrenia Scale: validation study. Rev Bras Psiquiatr 29: 246-249.
35. Levine SZ, Rabinowitz J (2007) Revisiting the 5 dimensions of the Positive and Negative Syndrome Scale. J Clin Psychopharmacol 27: 431-436. (Pubitemid 47415039)
36. Santos NP, Ribeiro-Rodrigues EM, Ribeiro-Dos-Santos AK, Pereira R, Gusmao L, et al. (2010) Assessing individual interethnic admixture and population substructure using a 48-insertion-deletion (INSEL) ancestry-informative marker (AIM) panel. Hum Mutat 31: 184-190.
37. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265. (Pubitemid 40202029)
38. Kumar P, Henikoff S, Ng PC (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4: 1073-1081.
39. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, et al. (2010) A method and server for predicting damaging missense mutations. Nat Methods 7: 248-249.
40. Desikan RS, Segonne F, Fischl B, Quinn BT, Dickerson BC, et al. (2006) An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31: 968-980. (Pubitemid 44183792)
41. Bender HU, Almashanu S, Steel G, Hu CA, Lin WW, et al. (2005) Functional consequences of PRODH missense mutations. Am J Hum Genet 76: 409-420. (Pubitemid 40250521)
42. Jacquet H, Raux G, Thibaut F, Hecketsweiler B, Houy E, et al. (2002) PRODH mutations and hyperprolinemia in a subset of schizophrenic patients. Hum Mol Genet 11: 2243-2249.
43. Jacquet H, Demily C, Houy E, Hecketsweiler B, Bou J, et al. (2005) Hyperprolinemia is a risk factor for schizoaffective disorder. Mol Psychiatry 10: 479-485. (Pubitemid 40646436)
44. Paterlini M, Zakharenko SS, Lai WS, Qin J, Zhang H, et al. (2005) Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice. Nat Neurosci 8: 1586-1594. (Pubitemid 41573674)
45. Sawa A (2009) Cortical development and glutamatergic dysregulation in schizophrenia. Biol Psychiatry 66: 530-532.
46. Bressan RA, Pilowsky LS (2003) [Glutamatergic hypothesis of schizophrenia]. Rev Bras Psiquiatr 25: 177-183.
47. Oresic M, Tang J, Seppanen-Laakso T, Mattila I, Saarni SE, et al. (2011) Metabolome in schizophrenia and other psychotic disorders: a general population-based study. Genome Med 3: 19.
48. Savio LE, Vuaden FC, Piato AL, Bonan CD, Wyse AT (2012) Behavioral changes induced by long-term proline exposure are reversed by antipsychotics in zebrafish. Prog Neuropsychopharmacol Biol Psychiatry 36: 258-263.
49. Rao ML, Gross G, Strebel B, Braunig P, Huber G, et al. (1990) Serum amino acids, central monoamines, and hormones in drug-naive, drug-free, and neuroleptic-treated schizophrenic patients and healthy subjects. Psychiatry Res 34: 243-257.
50. Jacquet H, Rapoport JL, Hecketsweiler B, Bobb A, Thibaut F, et al. (2006) Hyperprolinemia is not associated with childhood onset schizophrenia. Am JMed Genet B Neuropsychiatr Genet 141B: 192. (Pubitemid 43214796)
51. Tomiya M, Fukushima T, Watanabe H, Fukami G, Fujisaki M, et al. (2007) Alterations in serum amino acid concentrations in male and female schizophrenic patients. Clin Chim Acta 380: 186-190. (Pubitemid 46505332)
52. Servet C, Ghelis T, Richard L, Zilberstein A, Savoure A (2012) Proline dehydrogenase: a key enzyme in controlling cellular homeostasis. Front Biosci 17: 607-620.
53. Williams HJ, Williams N, Spurlock G, Norton N, Ivanov D, et al. (2003) Association between PRODH and schizophrenia is not confirmed. Mol Psychiatry 8: 644-645.
54. Walter H, Schlaff WB, Lesch OM, Vitek L, Zima T, et al. (2008) Breath alcohol level and plasma amino acids: a comparison between older and younger chronic alcohol-dependent patients. Alcohol Alcohol 43: 653-657.
55. Clelland CL, Read LL, Baraldi AN, Bart CP, Pappas CA, et al. (2011) Evidence for association of hyperprolinemia with schizophrenia and a measure of clinical outcome. Schizophr Res 131: 139-145.